Back to top
more

BellRing Brands (BRBR)

(Delayed Data from NYSE)

$36.68 USD

36.68
2,102,380

+0.05 (0.14%)

Updated Sep 18, 2025 04:00 PM ET

After-Market: $36.68 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 24% (186 out of 245)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how BellRing Brands (BRBR) and Durect (DRRX) have performed compared to their sector so far this year.

Zacks Equity Research

New Strong Buy Stocks for November 21st

by Zacks Equity Research

APH, WAB, BRBR, REZI and PINE have been added to the Zacks Rank #1 (Strong Buy) List on November 21, 2024.

Zacks Equity Research

BellRing Brands Inc. (BRBR) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

BellRing Brands (BRBR) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

BellRing Brands (BRBR) delivered earnings and revenue surprises of 2% and 2.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Wix Set to Report Q3 Earnings: Here's What Investors Should Know

by Zacks Equity Research

WIX's Q3 performance is likely to benefit from the adoption of AI product offerings as well as WIX Studio.

Zacks Equity Research

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Akoya (AKYA) delivered earnings and revenue surprises of 5.26% and 25.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

ICU Medical (ICUI) delivered earnings and revenue surprises of 27.20% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how BellRing Brands (BRBR) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.

Zacks Equity Research

Sonos to Report Q4 Earnings: Here's What Investors Should Know

by Zacks Equity Research

SONO's fiscal fourth-quarter performance is likely to have been affected by the delay in the launch of the new product due to issues with its app redesign fiasco.

Zacks Equity Research

BellRing Brands (BRBR) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the most recent trading session, BellRing Brands (BRBR) closed at $71.32, indicating a +0.89% shift from the previous trading day.

Zacks Equity Research

BellRing Brands (BRBR) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

BellRing Brands (BRBR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Why BellRing Brands (BRBR) Could Beat Earnings Estimates Again

by Zacks Equity Research

BellRing Brands (BRBR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Zacks Equity Research

Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Apyx (APYX) delivered earnings and revenue surprises of 6.67% and 1.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Insulet (PODD) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Insulet (PODD) delivered earnings and revenue surprises of 16.88% and 4.90%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

BellRing Brands (BRBR) Rises As Market Takes a Dip: Key Facts

by Zacks Equity Research

The latest trading day saw BellRing Brands (BRBR) settling at $67.52, representing a +1.24% change from its previous close.

Zacks Equity Research

BellRing Brands Inc. (BRBR) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

BellRing Brands (BRBR) Outperforms Broader Market: What You Need to Know

by Zacks Equity Research

The latest trading day saw BellRing Brands (BRBR) settling at $65.10, representing a +0.96% change from its previous close.

Zacks Equity Research

Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?

by Zacks Equity Research

Here is how AdaptHealth Corp. (AHCO) and BellRing Brands (BRBR) have performed compared to their sector so far this year.

Zacks Equity Research

BellRing Brands (BRBR) Upgraded to Strong Buy: Here's What You Should Know

by Zacks Equity Research

BellRing Brands (BRBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Equity Research

Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how BellRing Brands (BRBR) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.

Zacks Equity Research

Are Options Traders Betting on a Big Move in BellRing Brands (BRBR) Stock?

by Zacks Equity Research

Investors need to pay close attention to BellRing Brands (BRBR) stock based on the movements in the options market lately.

Zacks Equity Research

BellRing Brands (BRBR) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

BellRing Brands (BRBR) delivered earnings and revenue surprises of 22.73% and 2.34%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?